C

The Cooper Companies, Inc. COO

$56.57 $1.192.15% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. The company operates primarily through two business units: CooperVision and CooperSurgical. CooperVision develops and manufactures contact lenses, including toric, multifocal, spherical, and myopia management lenses, while CooperSurgical provides fertility, reproductive health, and gynecological medical devices and services. The company operates within the broader healthcare, medical technology, and specialty medical products industries, with revenue driven largely by recurring demand for disposable contact lenses and fertility-related products and procedures.

The company serves eye care professionals, fertility clinics, hospitals, surgical centers, and healthcare providers across developed and emerging markets. A key strategic advantage is its diversified exposure to both vision care and women’s health, including strong positions in specialty contact lenses and fertility treatment technologies. Founded in 1958, Cooper evolved from a diversified healthcare holding company into a focused medical technology enterprise through acquisitions, divestitures, and expansion into global healthcare markets. The company significantly expanded its women’s health business through acquisitions including Origio, LifeGlobal, and Generate Life Sciences, while continuing to build scale in contact lenses through manufacturing and product innovation.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Wednesday, September 9, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Beginning of December (est)

Price History

Loading...
52-Week Range14% of range
Low
$51.01
Current
$56.57
High
$89.83
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
925 460 3600
Address
6101 Bollinger Canyon Road
Suite 500
San Ramon, CA 94583
Country
Year Founded

Headlines